Peptisyntha is committed to serving the pharmaceutical and biotech industries with the production of cost effective and high quality bulk peptide APIs, based on close and long term relationships with the customers.   Peptisyntha continuously improves its scientific and technical expertise and its organization, in order to develop the best possible commercial scale production of bulk peptide APIs.   Peptisyntha aims at reducing the production costs of therapeutic peptides while minimizing the impact of the production processes on the environment.